| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 659590 | 69124 | OMEPRAZOL TEVA- RATIO 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TEVA- RATIO 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69124/69124_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69124/69124_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-07-17 | 1 | 1 | 1 | 2007-07-17 | 2007-07-17 | 1 | 2012-06-28 | View Edit Delete | ||||||||||||
| 659591 | 69124 | OMEPRAZOL TEVA- RATIO 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TEVA- RATIO 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69124/69124_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69124/69124_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-07-17 | 1 | 1 | 1 | 2007-07-17 | 2007-07-17 | 1 | 2014-12-09 | View Edit Delete | ||||||||||||
| 659592 | 69125 | OMEPRAZOL TEVA- RATIO 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL TEVA- RATIO 40 mg CAPSULAS DURAS GASTRORRESISTENTES, 14 cápsulas | 40 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69125/69125_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69125/69125_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-07-17 | 1 | 1 | 1 | 2007-07-17 | 2007-07-17 | 1 | 2012-06-28 | View Edit Delete | ||||||||||||
| 659593 | 69125 | OMEPRAZOL TEVA- RATIO 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL TEVA- RATIO 40 mg CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69125/69125_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69125/69125_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-07-17 | 1 | 1 | 1 | 2007-07-17 | 2007-07-17 | 1 | 2012-03-08 | View Edit Delete | ||||||||||||
| 659653 | 69155 | ALOPURINOL TEVA 300 mg COMPRIMIDOS EFG | ALOPURINOL TEVA 300 mg COMPRIMIDOS EFG , 30 comprimidos | 300 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69155/69155_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69155/69155_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-07-25 | 1 | 1 | 1 | 2007-07-25 | 2007-07-25 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 659858 | 69156 | ALOPURINOL TEVA 100 mg COMPRIMIDOS EFG | ALOPURINOL TEVA 100 mg COMPRIMIDOS EFG , 100 comprimidos | 100 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69156/69156_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69156/69156_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-07-25 | 1 | 1 | 1 | 2007-07-25 | 2007-09-18 | 1 | 2011-10-24 | 602667 | View Edit Delete | |||||||||||
| 659967 | 66147 | LANSOPRAZOL TEVA-RATIOPHARM 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TEVA-RATIOPHARM 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (BLISTER) | 15 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66147/66147_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66147/66147_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2004-06-14 | 1 | 1 | 1 | 2004-06-14 | 2007-10-04 | 1 | 2016-09-12 | View Edit Delete | ||||||||||||
| 659968 | 66147 | LANSOPRAZOL TEVA-RATIOPHARM 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TEVA-RATIOPHARM 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas (BLISTER) | 15 mg | 5 | 56 | 43 | 56 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66147/66147_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66147/66147_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2004-06-14 | 1 | 1 | 1 | 2004-06-14 | 2007-10-04 | 1 | 2017-04-11 | View Edit Delete | ||||||||||||
| 660007 | 69341 | FAMCICLOVIR TEVA 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | FAMCICLOVIR TEVA 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 250 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69341/69341_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69341/69341_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-10-18 | 1 | 1 | 1 | 2007-10-18 | 2007-10-18 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660044 | 69361 | MELTEVA 0,02 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | MELTEVA 0,02 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 21 comprimidos | 0,075 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69361/69361_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69361/69361_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-10-25 | 1 | 1 | 1 | 2007-10-25 | 2007-10-25 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660045 | 69361 | MELTEVA 0,02 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | MELTEVA 0,02 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 63 (3 x 21) comprimidos | 0,075 mg/0,02 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69361/69361_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69361/69361_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-10-25 | 1 | 1 | 1 | 2007-10-25 | 2007-10-25 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660046 | 69362 | TEVALET 0,03 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS | TEVALET 0,03 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS, 21 comprimidos | 0,075 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69362/69362_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69362/69362_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-10-25 | 1 | 1 | 1 | 2007-10-25 | 2007-10-25 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660047 | 69362 | TEVALET 0,03 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS | TEVALET 0,03 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS, 63 (3 x 21) comprimidos | 0,075 mg/0,03 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69362/69362_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69362/69362_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-10-25 | 1 | 1 | 1 | 2007-10-25 | 2007-10-25 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660099 | 69387 | MIRTAZAPINA TEVAGEN 15 mg COMPRIMIDOS BUCODISPERSABLES EFG | MIRTAZAPINA TEVAGEN 15 mg COMPRIMIDOS BUCODISPERSABLES EFG , 30 comprimidos | 15 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69387/69387_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69387/69387_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-11-12 | 1 | 1 | 1 | 2007-11-12 | 2007-11-12 | 1 | 2021-02-11 | View Edit Delete | ||||||||||||
| 660101 | 69388 | MIRTAZAPINA TEVAGEN 30 mg COMPRIMIDOS BUCODISPERSABLES EFG | MIRTAZAPINA TEVAGEN 30 mg COMPRIMIDOS BUCODISPERSABLES EFG , 30 comprimidos | 30 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69388/69388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69388/69388_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-11-12 | 1 | 1 | 1 | 2007-11-12 | 2007-11-12 | 1 | 2021-02-11 | View Edit Delete | ||||||||||||
| 660154 | 69418 | ALFUZOSINA TEVA-RATIOPHARM 10 mg COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG | ALFUZOSINA TEVA-RATIOPHARM 10 mg COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69418/69418_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69418/69418_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-11-26 | 1 | 1 | 1 | 2007-11-26 | 2007-11-26 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 658945 | 68745 | ANESTEFARIN 5 mg/5 mg COMPRIMIDOS PARA CHUPAR | ANESTEFARIN 5 mg/5 mg COMPRIMIDOS PARA CHUPAR , 20 comprimidos | 5 mg/5 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68745/68745_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68745/68745_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8352 | FARLINE COMERCIALIZADORA DE PRODUCTOS FARMACEUTICOS S.A. | 2007-05-09 | 1 | 1 | 1 | 2007-05-09 | 2007-05-09 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 659290 | 60740 | LACEROL COR RETARD 240 mg COMPRIMIDOS DE LIBERACION PROLONGADA | LACEROL COR RETARD 240 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 240 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60740/60740_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60740/60740_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4840 | LACER S.A. | 1995-10-01 | 1 | 1 | 1 | 1995-10-01 | 2007-06-12 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 659672 | 62103 | VIRLIX PLUS COMPRIMIDOS DE LIBERACION PROLONGADA | VIRLIX PLUS COMPRIMIDOS DE LIBERACION PROLONGADA , 14 comprimidos | 5 mg/120 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62103/62103_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62103/62103_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4840 | LACER S.A. | 2003-05-07 | 1 | 1 | 1 | 2003-05-07 | 2003-05-07 | 1 | 2011-09-23 | View Edit Delete | ||||||||||||
| 658969 | 68755 | OLANZAPINA STADA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA STADA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68755/68755_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68755/68755_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-05-04 | 1 | 1 | 1 | 2007-05-04 | 2007-05-04 | 1 | 2011-05-09 | View Edit Delete |
Page 140 of 1036, showing 20 records out of 20709 total, starting on record 2781, ending on 2800